The fall 2019 Cancer Today tells the stories of advocates who are using the internet to amplify their voices, patients who are navigating the world of complementary medicine and researchers who are devising new immunotherapies.

by Kevin McLaughlin

Article describes efforts to support cancer survivors, radiation meeting focuses on treatment de-escalation, and studies show that brain tumor cells have their own neural network.

by Marci A. Landsmann

Organizations release guidelines on reducing breast cancer risk using medications, and a palliative care doctor discusses the pros and cons of dying at home.

by Kate Yandell

A study looks at hormone therapy and breast cancer risk, and researchers take a closer look at marijuana use in young cancer patients.

by Marci A. Landsmann

Recommendations say that a broader group of women should be considered for BRCA mutation testing, and the U.S. Food and Drug Administration issues a proposal to require that cigarettes come with graphic warnings.

by Kate Yandell

A radiation oncologist draws on her personal experience as she researches financial toxicity, and the U.S. Food and Drug Administration issues a third tissue-agnostic approval.

by Kate Yandell

A liquid biopsy test is effective in detecting a cancer biomarker, Medicare opts to cover CAR-T cell therapies, and an e-cigarette maker spends millions to defeat a ban on sales in San Francisco.

by Kevin McLaughlin

The U.S. Food and Drug Administration for the first time approves an immune checkpoint inhibitor for treatment of esophageal cancer, and a two-drug combination shows promise for treating chronic lymphocytic leukemia.

by Kate Yandell

The U.S. Food and Drug Administration requests a recall of textured breast implants, and a study indicates BRCA2 mutations are associated with non-Hodgkin lymphoma.

by Kate Yandell

A study sheds light on the effects of hurricanes on cancer patients receiving radiation therapy, and the Biden Cancer Initiative suspends operations.

by Kate Yandell and Bradley Jones